newsfilter
← Latest News
Business Wire·

Xeris Pharmaceuticals Stockholders Approve Acquisition of Strongbridge Biopharma

Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) ("Xeris") today announced that its stockholders have voted to approve the previously announced proposed acquisition of Strongbridge Biopharma plc (NASDAQ:SBBP) ("Strongbridge") by Xeris. At the special meetin